|
|
Article: SMITHKLINE BEECHAM: Bactroban Nasal to decrease risk of S. aureus nosocomial infections in patients.
- Article from:
- M2 Presswire
- Article date:
- April 23, 1999
CopyrightCOPYRIGHT 1999 Normans Media Ltd. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
M2 PRESSWIRE-23 April 1999-SMITHKLINE BEECHAM: SmithKline Beecham's Bactroban Nasal shown to decrease risk of S. aureus nosocomial infections in surgical patients (C)1994-99 M2 COMMUNICATIONS LTD
RDATE:190499
* New Study Suggests Role for Prophylaxis in Reducing Incidence of Life-Threatening and Costly Infections
SAN FRANCISCO, CA -- The pre-operative use of Bactroban Nasal (mupirocin calcium ointment, 2%, SmithKline Beecham), a broad-spectrum, topical antibiotic, significantly decreases the risk of Staphylococcus aureus (S. aureus) nosocomial infections among surgical patients, according to a new study reported today at the annual meeting of ...